FoundryBridge is a Healthcare Venture Advisory bridging Israeli deep-tech innovation to global markets, partnering with founders, venture funds, and innovation programs.
FoundryBridge exists to close the gap between breakthrough science and successful healthcare ventures at scale — working at every stage from discovery to formation to ecosystem connection
Identifying promising science is only the beginning. The real challenge is recognizing where innovation has the potential to become a successful healthcare venture.
Scientific breakthroughs become successful ventures by systematically closing the commercial gap — through commercial design and strategy from day one.
Successful ventures grow through the right relationships — connecting founders with the expertise, partners, and ecosystem that help move innovation forward.
Engaging with healthcare investors to surface Israeli ventures through scouting, opportunity sourcing, due diligence, commercial validation, founder introductions, and ecosystem insight.
Supporting entrepreneurs and founders transform breakthrough technologies into venture-ready companies through commercialization strategy, market validation, business design, and fundraising readiness.
Direct relationships across Israel's health-tech ecosystem — university and hospital TTO pipelines including Hadassit, Ramot (TAU), Yissum, T3 (Technion), ARC (Sheba), and Rambam MedTech — alongside strategic connections to corporate innovators, and global healthcare organizations.
Advising healthcare ventures on product strategy, technology architecture, AI-driven transformation, R&D leadership, and regulated software development — from early concept through scalable execution.
FoundryBridge engages at the formation stage — partnering with founders, academic tech transfer offices, and clinician-innovators before a company has fully formed, establishing the commercial, technical, and strategic foundations that institutional investors expect.
Capital Efficiency and Structural Upside — Academic IP arrives with years of R&D already absorbed — typically representing $5M+ of prior development investment. This structural maturity reduces capital burn, enables higher ownership in a de-risked opportunity, and shortens time to institutional funding milestones.
Yinon Amir is a venture builder and business-technology executive with 25+ years operating at the intersection of Israeli deep-tech health innovation, corporate venture, and startup formation.
Executive leadership spanning R&D organizations at Philips, DarioHealth, and Amdocs — and as co-founder and CEO of an early-stage digital health startup — he brings both operator depth and founder perspective to every engagement. Known for building and scaling high-performing engineering organizations, driving corporate innovation, and connecting deep-tech with commercial outcomes.
Currently engaged with venture funds and founders on thematic scouting, deal flow, and due diligence.
View LinkedIn Profile
Active in Israeli health-tech startups, scouting, deal flow, startups due diligence, and venture ecosystem development
GTM strategy, commercial model design, and US market entry for deep-tech health founders
25+ years leading global R&D organizations across digital health, medical devices, and enterprise software
Whether you're a founder shaping a new venture, a fund exploring Israeli deep-tech health, or a partner building in this ecosystem — if you're working at the intersection of science and venture, let's talk.